...
首页> 外文期刊>BioPsychoSocial Medicine >Psychosomatic treatment for allergic diseases
【24h】

Psychosomatic treatment for allergic diseases

机译:过敏性疾病的心身治疗

获取原文
           

摘要

Summary Many reports have been published concerning how psychosocial stress influences the occurrence and progression of allergic diseases such as bronchial asthma and atopic dermatitis. As for asthma, a typical allergic disease often accompanied by psychosomatic related problems, the Global Initiative for Asthma (GINA), international medical guidelines for asthma, describes psychosocial problems as causative factors of poor asthma control and as risk factors for asthma exacerbation, even if symptoms are well controlled. However, because there is little high quality evidence for effective treatments for asthma patients with psychosocial problems, concrete assessments and treatments for such problems is scarcely described in GINA. Therefore, psychosomatic intervention for asthma patients is not effectively conducted on a worldwide scale. In contrast, the “Japanese Guidelines for the Diagnosis and Treatment of Psychosomatic Diseases” describe the assessment and treatment of psychosomatic disorders in detail. In the guidelines, psychosocial factors are classified into five categories; 1) Relation between stress and asthma occurrence or progression, 2) Relation between emotion and asthma symptoms, 3) Problems related to a patient’s character and behaviors, 4) Problems of daily life and Quality of Life (QOL), and 5) Problems related to family relationships and life history. The employment of a self-administered questionnaire, the “Psychosomatic Questionnaire related to Asthmatic Occurrence and Progression”, is useful for clarifying psychosocial factors and for setting up treatment strategies according to the problems identified. The Japanese guidelines have been proven to be useful, but empirical evidence for their effectiveness is still relatively limited. It will be necessary in the future to accumulate high-quality evidence and to revise the psychosomatic approaches in the guidelines that are universally valid.
机译:小结关于心理社会压力如何影响过敏性疾病(如支气管哮喘和特应性皮炎)的发生和发展,已经发表了许多报告。对于哮喘,一种典型的过敏性疾病,通常伴随着心身相关的问题,全球哮喘倡议(GINA),即哮喘的国际医学指南,将心理社会问题描述为哮喘控制不佳的病因和哮喘加重的危险因素,即使症状得到良好控制。但是,由于对于有心理社会问题的哮喘患者的有效治疗的高质量证据很少,因此GINA几乎没有描述对此类问题的具体评估和治疗。因此,针对哮喘患者的心身干预并未在全球范围内有效地进行。相反,“日本心身疾病诊断和治疗指南”详细描述了心身疾病的评估和治疗。在指导方针中,社会心理因素分为五类。 1)压力与哮喘的发生或发展之间的关系; 2)情绪与哮喘症状之间的关系; 3)与患者的性格和行为有关的问题; 4)日常生活和生活质量(QOL)问题; 5)相关问题家庭关系和生活史。使用自我管理的调查表“与哮喘发生和进展有关的心身问卷”对于阐明社会心理因素和根据发现的问题制定治疗策略很有用。日本指南已被证明是有用的,但是其有效性的经验证据仍然相对有限。将来有必要积累高质量的证据并修改普遍有效的指南中的心身方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号